全文获取类型
收费全文 | 2811篇 |
免费 | 195篇 |
国内免费 | 8篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 91篇 |
妇产科学 | 46篇 |
基础医学 | 377篇 |
口腔科学 | 125篇 |
临床医学 | 373篇 |
内科学 | 472篇 |
皮肤病学 | 34篇 |
神经病学 | 150篇 |
特种医学 | 276篇 |
外科学 | 335篇 |
综合类 | 89篇 |
现状与发展 | 1篇 |
一般理论 | 3篇 |
预防医学 | 347篇 |
眼科学 | 39篇 |
药学 | 134篇 |
中国医学 | 5篇 |
肿瘤学 | 108篇 |
出版年
2023年 | 16篇 |
2022年 | 13篇 |
2021年 | 38篇 |
2020年 | 27篇 |
2019年 | 43篇 |
2018年 | 55篇 |
2017年 | 33篇 |
2016年 | 51篇 |
2015年 | 57篇 |
2014年 | 76篇 |
2013年 | 72篇 |
2012年 | 97篇 |
2011年 | 97篇 |
2010年 | 67篇 |
2009年 | 98篇 |
2008年 | 117篇 |
2007年 | 127篇 |
2006年 | 114篇 |
2005年 | 95篇 |
2004年 | 90篇 |
2003年 | 94篇 |
2002年 | 72篇 |
2001年 | 71篇 |
2000年 | 96篇 |
1999年 | 75篇 |
1998年 | 68篇 |
1997年 | 88篇 |
1996年 | 83篇 |
1995年 | 72篇 |
1994年 | 64篇 |
1993年 | 66篇 |
1992年 | 57篇 |
1991年 | 57篇 |
1990年 | 60篇 |
1989年 | 69篇 |
1988年 | 62篇 |
1987年 | 69篇 |
1986年 | 61篇 |
1985年 | 46篇 |
1984年 | 44篇 |
1983年 | 34篇 |
1982年 | 36篇 |
1981年 | 19篇 |
1980年 | 14篇 |
1979年 | 17篇 |
1978年 | 13篇 |
1977年 | 15篇 |
1976年 | 15篇 |
1975年 | 19篇 |
1970年 | 10篇 |
排序方式: 共有3014条查询结果,搜索用时 15 毫秒
1.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
2.
3.
4.
5.
This is an analysis of 37 previously untreated patients with squamous cell carcinoma of the maxillary sinus treated with curative intent at the University of Florida from January 1966 through January 1984. All patients were followed for at least two years and 86 per cent (32/27) were followed for a minimum of five years. Patients were treated for cure with radiation therapy alone (25), surgery alone (1), or surgery and preoperative (6) or postoperative (5) radiation therapy. This study presents the results of treatment and the incidence of treatment-related complications in this group of patients. 相似文献
6.
7.
8.
Larry E. Davis Mario Kornfeld Herbert S. Mooney Kurt J. Fiedler Kathleen Y. Haaland William W. Orrison Elsa Cernichiari Thomas W. Clarkson 《Annals of neurology》1994,35(6):680-688
For 3 months in 1969 a family in the United States that included a pregnant mother consumed pork containing methylmercury. Children, aged 20, 13, and 8 years and a neonate, developed severe neurological signs. Twenty-two years later, the 2 oldest had cortical blindness or constricted visual fields, diminished hand proprioception, choreoathetosis, and atentional deficits. Magnetic resonance images showed tissue loss in the calcarine and parietal cortices and cerebellar folia. The youngest had quadriplegia, blindness, and severe mental retradation until their deaths. The brain of the 8-year-old who died at age 30 showed cortical atrophy, neuronal loss, and gliosis, most pronounced in the paracentral and parietooccipital regions. The total mercury level in formalin-fixed, left occipital cortex was 1,974 ng/gm as measured by atomic absorption. Regional brain mercury levels correlated with extent of brain damage. A control patient had 38.5 ng of mercury/gm in the occipital cortex. Systemic organs in the patient and a control subject had comparable mercury levels. In mercury-intoxicated rats, we found that only 5 to 10% of total brain mercury was lost by formalin fixation. Brain inorganic mercury in the patient ranged from 82 to 100%. Since inorganic mercury crosses the blood-brain barrier poorly, biotransformation of methyl to inorganic mercury may have occurred after methylmercury crossed the blood-brain barrier, accounting for its persistence in brain and causing part of the brain damage. 相似文献
9.
10.